Medical Monitoring Provider Dexcom's Stock Drops 40% as Q2 Revenue Misses Estimates, Lowers Full-Year Guidance

  • 3 months ago
Dexcom's stock plunged nearly 40% after the company reported second-quarter revenue that missed estimates and lowered its full-year guidance.
Transcript
00:00It's Benzinga and here's what's on the block.
00:02Dexcom stock plunged nearly 40% after the company reported second quarter revenue that
00:07missed estimates and lowered its full year guidance.
00:10The company provides a range of continuous glucose monitoring tools for individuals diagnosed
00:15with diabetes.
00:16Revenue fell short of expectations and the company reduced its revenue guidance for both
00:20the third quarter and the full year.
00:22The CEO attributed the miss to the restructuring of the sales force, fewer new customers and
00:27lower revenue per user than expected.
00:29Challenges in the durable medical equipment channel also hurt results as key partners
00:33struggle.
00:34For all things money, visit Benzinga.com.

Recommended